June 12, 2017 / 11:29 AM / 3 months ago

BRIEF-Cannimed Therapeutics' Q2 loss per share $0.08

June 12 (Reuters) - Cannimed Therapeutics Inc

* Cannimed Therapeutics Inc reports financial results for Q2 2017

* Qtrly revenue increased to $3.7 million from $2.2 million for comparable period in previous fiscal year

* Qtrly loss per share $0.08 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below